4th Quarter - Report
VENN STRATEGIES for UCB, INC.
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Policies related to biopharmaceutical access and innovation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN PYATT | — |
| MICHAEL SPIRA | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| UCB S.A. | Belgium | Belgium | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.